A FRAMEWORK FOR REAL-WORLD ECONOMIC EVALUATION BY INCORPORATING IMPLEMENTATION PARAMETERS

Author(s)

Janneke PC. Grutters, PhD, Researcher1, Manuela A. Joore, PhD, Researcher21Maastro Clinic, Maastricht, Netherlands; 2 University Hospital Maastricht, Maastricht, Netherlands

OBJECTIVES: Reimbursement decisions are often supported by economic evaluations based on randomised controlled trials (RCTs). A problem with RCTs is that they usually deviate from daily practice. Hence, reimbursement decisions are based on perfect-world assessments of cost-effectiveness. In daily practice, the technology is likely to be less cost-effective for instance due to lower compliance. To make real-world reimbursement decisions, factors that potentially influence the cost-effectiveness should be considered. These factors are implementation factors, and stochastic in nature. This study presents a framework that incorporates the implementation of a technology directly into the economic evaluation, thus anticipating on potentially less than perfect implementation. This results in real-world economic evaluations. METHODS: The framework allows for a stepwise consideration of the net benefit (NB) of a technology in different states of the world: 1) perfect-world (NB under perfect implementation); 2) real-world (NB under expected implementation); and 3) improved-world (NB after intervention to improve implementation). Step 1 tells us whether the technology could be cost-effective. Step 2 gives us the real world cost-effectiveness. The difference between the NB of step 1 and 2 gives the upper bound of the value of improving implementation. Step 3 tells us whether it is cost-effective to invest in specific interventions to improve implementation. The implementation factors are stochastic, therefore in each step parameter uncertainty is addressed in probabilistic sensitivity analyses, and the value of reducing uncertainty is examined in value of information analyses. RESULTS: As a case we used a Markov model that examines the cost-effectiveness of direct hearing aid provision versus provision by referral. Two stochastic implementation parameters were incorporated: patient compliance and professional uptake. The upper bound of the value of improving implementation was €50 million (patient compliance), €23 (professional uptake) and €72 million in total. This suggests that implementation interventions may be valuable (results presented at the conference). METHODS: CONCLUSIONS: This framework allows for real-word economic evaluations to inform policy decisions.

Conference/Value in Health Info

2008-11, ISPOR Europe 2008, Athens, Greece

Value in Health, Vol. 11, No. 6 (November 2008)

Code

PMC14

Topic

Economic Evaluation, Methodological & Statistical Research

Topic Subcategory

Cost/Cost of Illness/Resource Use Studies, Modeling and simulation

Disease

Multiple Diseases

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×